Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The pathogens profile in children with otitis media with effusion and adenoid hypertrophy

  • G. P. Buzatto,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • E. Tamashiro,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • J. L. Proenca-Modena,

    Affiliation Department of Genetics, Evolution, and Bioagents, Institute of Biology, University of Campinas (UNICAMP), Biology Institute, Campinas, São Paulo, Brazil

  • T. H. Saturno,

    Affiliation Department of Molecular and Cell Biology, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • M. C. Prates,

    Affiliation Department of Molecular and Cell Biology, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • T. B. Gagliardi,

    Affiliation Department of Molecular and Cell Biology, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • L. R. Carenzi,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • E. T. Massuda,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • M. A. Hyppolito,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • F. C. P. Valera,

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • E. Arruda,

    Affiliation Department of Molecular and Cell Biology, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

  • W. T. Anselmo-Lima

    Affiliation Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil

The pathogens profile in children with otitis media with effusion and adenoid hypertrophy

  • G. P. Buzatto, 
  • E. Tamashiro, 
  • J. L. Proenca-Modena, 
  • T. H. Saturno, 
  • M. C. Prates, 
  • T. B. Gagliardi, 
  • L. R. Carenzi, 
  • E. T. Massuda, 
  • M. A. Hyppolito, 
  • F. C. P. Valera



To evaluate the presence of viruses and bacteria in middle ear and adenoids of patients with and without otitis media with effusion (OME).


Adenoid samples and middle ear washes (MEW) were obtained from children with OME associated with adenoid hypertrophy undergoing adenoidectomy and tympanostomy, and compared to those obtained from patients undergoing cochlear implant surgery, as a control group. Specific DNA or RNA of 9 respiratory viruses (rhinovirus, influenza virus, picornavirus, syncytial respiratory virus, metapneumovirus, coronavirus, enterovirus, adenovirus and bocavirus) and 5 bacteria (S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa and S. aureus) were extracted and quantified by real-time PCR.


37 OME and 14 cochlear implant children were included in the study. At the adenoid, virus and bacteria were similarly detected in both OME and control patients. At the middle ear washes, however, a higher prevalence of bacteria was observed in patients with OME (p = 0.01). S. pneumoniae (p = 0.01) and M. catarrhalis (p = 0.022) were the bacteria responsible for this difference. Although total virus detection was not statistically different from controls at the middle ear washes (p = 0.065), adenovirus was detected in higher proportions in adenoid samples of OME patients than controls (p = 0.019).


Despite both OME and control patients presented similar rates of viruses and bacteria at the adenoid, children with OME presented higher prevalence of S. pneumonia, M. catarrhalis in middle ear and adenovirus in adenoids when compared to controls. These findings could suggest that these pathogens could contribute to the fluid persistence in the middle ear.


Otitis media with effusion (OME) is a common childhood disease characterized by the presence of fluid in the middle ear, with no symptoms and/or signs of acute inflammation [1, 2]. In the United States, approximately 90% of all children develop an episode of OME before they reach school age, mainly between the ages of 4 months and 6 years [2]. The presence of OME is associated with severe negative impact on child development, including hearing loss with long-term consequences for speech and language acquisition, poor school performance, and imbalance issues [13]. Moreover, children with OME are five times more susceptible to develop acute otitis media than controls [4, 5].

The pathogenesis of OME is still not fully understood. Epidemiological data suggest that the pathogenesis of OME is multifactorial, involving anatomical, immunological, genetic, microbial, and environmental factors [69]. However, it is widely accepted that the dysfunction of the Eustachian tube play a key role in the development of OME in all ages.

Mechanical obstruction of the Eustachian tube is one of the main identifiable causes of Eustachian tube dysfunction, especially due to adenoid hypertrophy (AH) in the pediatric age. The presence of AH can obstruct the nasopharyngeal ostium of the Eustachian tube, leading to negative pressure in the middle ear cavity, and eventually mucosal transudation [10]. Indeed, AH is a frequent condition observed in patients with OME [79, 11]. In children with AH and OME, the surgical removal of the adenoid (associated with ventilation tube insertion) accelerates the recovery of the middle ear mucosa, decrease the risk of recurrence and need of repetitive surgical procedures, and reduce treatment failure rate. However, new evidence point out that the benefits of adenoidectomy in children with OME older than 4 years-old is independently of the adenoid size [12], suggesting that the removal of a local reservoir of pathogenic microbiota (viruses, planktonic bacteria, and biofilms) is the key for such benefits [1315]. Despite some studies have evaluated the microbial colonization of adenoid and middle ear, no studies have thoroughly studied the association of respiratory pathogenic microbiota between these two niches. Therefore, the present study was carried out to compare the detection of common respiratory viruses and bacteria in adenoids and middle ear fluid in children with OME and in controls.

Moreover, adenoid can be reservoirs of pathogens that may reach the middle ear [13]. Adenoid samples obtained from patients with chronic adenoiditis are highly colonized by multiple species of viruses and bacteria. The rate of detection in hypertrophic adenoids is higher than 85% for viruses [14] and almost 100% for bacteria [15].

Bacteria and viruses have been detected in the middle ear fluid (MEF) from children with OME. Using an RT-PCR-based assay only for three respiratory viruses (rhinovirus, respiratory syncytial virus and human coronavirus), positivity was detected in 30% of MEF from children with OME in Finland [16]. In a study conducted in Pittsburgh, 75 of 97 (77.3%) samples of MEF from children with OME were positive by PCR for one or more of three bacteria (M catarrhalis, H influenza and S pneumoniae) [17].


Ethics statement

The study was conducted following the principles expressed in the Declaration of Helsinki, after approval by the Ethics Review Committee of the Clinical Hospital of the University of Sao Paulo School of Medicine in Ribeirão Preto, Brazil (#10466/2008). Written informed consent was obtained from all parents/guardians.


The study enrolled patients seen at the Division of Otorhinolaryngology from May 2010 to August 2012. Two groups of patients were studied: a) children with OME and adenoid hypertrophy (AH) who underwent adenoidectomy and tympanostomy with ventilation tube insertion, and b) children with no middle ear disease, who underwent cochlear implantation due to severe hearing loss. All patients were evaluated by otoscopy, audiometry, tympanometry, and nasal endoscopy. OME was diagnosed by medical history suggesting persistence of middle ear fluid for more than 3 months without acute signs of inflammation, confirmed by the presence of tympanic membrane opacity, retraction, or air-liquid interface, and by a type B tympanogram and/or conductive hearing loss. AH was defined at nasal endoscopy by the presence of adenoid in contact with the torus tubaris (grade 3) and/or vomer (grade 4) [18, 19]. Exclusion criteria were: prior surgical procedures in the upper airways, including tympanostomy for tube placement; use of antibiotics or symptoms of respiratory infection within the last month; history of recurrent acute otitis media or recurrent upper airways infection; tympanic membrane perforation, or the presence of genetic syndromes, such as Down syndrome. All patients with OME and AH were under treatment with nasal corticosteroids for at least one month during the preoperative period.

The control group consisted of children undergoing cochlear implant due to severe hearing loss with no medical history of otitis media, no respiratory infection within the last month, absence of tympanometric alterations, nor adenotonsillar hypertrophy.

All patients followed the vaccination protocols of the Brazilian ministry of health [20], which includes some pathogens targeted in the present study, such as pneumococcal conjugated. Additionally, patients in the control group were immunized with pneumococcus 23-valent vaccine and meningococcus C, according to the cochlear implant surgery protocol.

Specimen collection

Fragments of adenoid (surface and stroma) and middle ear washes (MEW) were obtained from all patients under general anesthesia. Briefly, adenoids fragments were collected using Beckmann adenoid curette (from OME-AH patients) or punch biopsy forceps, under direct visualization after soft palate retraction, in order to avoid contamination (controls). Adenoids samples were placed in Eagle’s minimal essential medium (MEM) with 15% of a solution containing 20,000 U/mL of penicillin-streptomycin and 200 μg/mL of amphotericin B, 10% of fetal bovine serum (Gibco®, Life Technologies, Carlsbad, CA, USA), and kept on ice until further processing. Adenoids were washed twice in MEM to remove blood and tissue debris and the fragment was macerated in Trizol® (Invitrogen, Life Technologies, Carlsbad, CA, USA) for later nucleic acid extraction.

In children with OME, MEW was performed with 0.5 mL of sterile saline through a small tympanostomy using a sterile needle coupled to a 5 mL syringe, after mechanical cleaning of the external ear canal. After that, the MEW was conditioned into a polypropylene microtube and treated with antimycotic and antibiotic solution (Gibco®, Grand Island, NY, USA) for one hour at 4°C. Aliquots were made in thrice the volume of Trizol, and frozen at −80°C until further processing. From each patient, samples were collected from only one side, which was randomly chosen when bilateral disease was present.

In control patients, MEW was obtained after partial mastoidectomy was performed, when direct access to the middle ear was possible through the attic, with the same sterile technique utilized to collect samples in OME patients.

Nucleic acid extraction and pathogen detection

RNA was extracted from 250 μL of MEW or from approximately 30 mg of adenoid tissue using 750 μL of Trizol® [21], according to the manufacturer’s protocol. DNA was further extracted using DNA purification kit (Promega®, Fitchburg, WI, USA) starting with the DNA-enriched fraction obtained with Trizol®. Samples were tested by real-time PCR for rhinovirus (HRV), influenza virus (FLU), parainfluenza virus (HPIV), syncytial respiratory virus (HRSV), metapneumovirus (HMPV), coronavirus (HCoV), enterovirus (HEV), adenovirus (HAdV) and human bocavirus (HBoV) following an in house real-time PCR protocol, based on primers listed on S1 Table and TaqMan probes, with the same procedures published elsewhere (14]. Real-time PCR was also used to detect the presence of S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa, and S. aureus, using the primers listed on S2 Table.

Statistical analysis

The Fisher’s exact test was used to compare rates of virus and bacteria detection in both groups of patients. Wilcoxon test was done to assess correlation between bacteria and virus detected in each patient. The analysis was performed using GraphPad Prism 5 (La Jolla, CA, USA).


Clinical data

14 control patients (2–12 years-old; mean 4 years 6 months; SD 2.64; 9 male / 5 female) and 37 children with OME and AH (2–12 years-old; mean 6 years 1 month; SD 1,97; 19 male / 18 female) were included in this study.

No severe complications related to the sampling procedure, such as nasal or oral bleeding, dysphagia and otorrhea, were observed in the control group as well as in the OME-AH group within the first 48 hours after surgery or after 3 weeks postoperative reassessment.

Detection of viruses

At least one virus species was detected, considering adenoid samples, in 32 of 37 (86.5%) patients with OME-AH and in 11 of 14 (78.6%) control patients. Differently, at least one virus was detected in MEWs from 19 of 37 (51.3%) patients with OME, and in 3 of 14 (21.4%) control patients.

The overall rates of virus detection were significantly higher in adenoids as compared to MEW in both groups (p = 0.002 for the OME group and p = 0.007 for the control group), but the virus detection rates in MEW and adenoids were not significantly different between patients with OME and control children (respectively p = 0.06 and p = 0.66). Despite this fact, HAdV was more often found in adenoids of OME-AH group as compared to controls (p = 0.01) (Table 1).

Table 1. Viral detection in adenoid and middle ear samples from OME and control patients.

The rates of virus co-detection in positive samples were 59.3% (19/32) in adenoids and 21% (4/19) in MEWs. Two or 3 viruses were simultaneously detected in adenoid tissues from 15 (40.5%) and 4 (10.8%) patients with OME. In contrast, only 3 (8.1%) control patients had 2 viruses and only 1 (2.7%) had 3 different viruses detected in MEWs (Fig 1). There was no significant concordance between detection of viruses in adenoid and the middle ear (p = 0.65). Only 6 (16.2%) patients with OME (5 HEV and 1 HBoV) and 1 control patient (HEV) had the same virus detected in MEWs and adenoid tissue, suggesting that the viral colonization of the middle ear is independent from viral infection of adenoids.

Fig 1. Percentages of single infections and co-infections by respiratory viruses in adenoids and middle ear samples from OME and control patients.

Detection of bacteria

Notably, the rates of bacteria detection in MEWs was significantly higher in patients with OME than in control patients (p = 0.01), especially due to S. pneumococcus and M. catarrhalis. Overall bacterial detection rates in adenoids were similar between OME and control patients (p = 0.29). Twelve of 14 control patients (85.7%) had at least one species of respiratory pathogenic bacteria detected in adenoid tissues, reinforcing previous data that indicate that potentially pathogenic bacteria colonize adenoids of healthy children [22, 23] (Table 2).

Table 2. Bacterial detection in adenoid and middle ear samples from OME and control patients.

With regard to bacteria co-detection in adenoids and MEWs from OME patients, 18 patients (48.6%) with OME had more than one bacterium detected in adenoid, and two, three, or four bacteria were simultaneously detected respectively in 16.2%, 18.9%, and 13.5% of patients. Six patients had 2 (16.2%), four had 3 (10.8%) and two patients had 4 bacteria (5.4%) simultaneously detected in MEWs for an overall frequency co-detection of bacteria in MEWs of 32.4% (12 of 37 patients). Bacteria co-detection was also frequent in the control group, in which five patients had 2, three patients had 3 and one patient had 4 different bacteria simultaneously detected in adenoid tissues. Bacteria co-detection was not observed in MEWs from control patients (Fig 2).

Fig 2. Percentages of single infections and co-infections by potentially pathogenic bacteria in adenoids and middle ear samples from OME and control patients.

Similar to the findings regarding viruses, there was no concordance between bacteria detected in adenoids and MEWs, both in controls and OME patients (p = 0.18). The same bacteria were detected in the MEWs and adenoids was observed in 13 (35.1%) patients with OME, and in 2 (14.2%) controls (Fig 2).

Association between virus and bacteria detection

Multiple associations between viruses and bacteria in the adenoid and middle ear were investigated. The only microbes that presented positive association was S. pneumoniae and HAdV in hypertrophic adenoids of patients with OME (p = 0.02) (Tables 3 and 4). We did not find any significant association between virus and bacteria in the adenoid or middle ear in patients of the control group.

Table 3. Detection of respiratory viruses and bacteria in adenoid samples in patients with OME.

Table 4. Detection of respiratory viruses and bacteria in adenoid samples from control patients undergoing cochlear implantation.


Although the pathogenesis of OME is not fully understood, there is evidence that adenoid may play an important role in this disease, either by mechanically impairing the Eustachian tube function, or by acting as a microbial reservoir for ascending infection to the middle ear [13, 14, 24]. Children are often exposed to pathogens that may chronically persist in tissues in the upper airways, especially in the adenoid and tonsils [13, 14, 25, 26]. Thus, as the adenoid has an intimate anatomical relation with the Eustachian tube and ultimately to the middle ear, it is important to understand how the presence of microbes in the adenoid could lead to the development or persistence of OME in children.

To the best of our knowledge, this is the first case-control study that compared adenoid and middle ear microbiota of OME patients with healthy children. In our study, we used a sensitive method to detect nucleic acid of a comprehensive panel of respiratory viruses and bacteria to compare the microbial colonization of adenoid and its correspondence in the middle ear in both OME children and controls.

The overall detection rate of bacteria in the middle ear was significantly higher in patients with OME than in controls, but was similar for viruses. The higher overall frequency of bacteria detection in MEWs from OME patients was expected, since the accumulation of middle ear effusion favors growing of bacterial elements that may have been suctioned through the tube from the nasopharyngeal microbiota. Moreover, these bacteria may play roles as chronic inflammatory stimuli to the mucosa of the middle ear and contribute to the dysfunction of Eustachian tube. There was little or no concordance of the microbe detected in the adenoid and the middle ear, both in patients with OME as well as in controls. This finding is in agreement with a previous report that performed 16S rDNA pyrosequencing of both niches, showing that the adenoid microbiota was more diverse and complex than of the middle ear in a child with OME [27]. As the adenoid is exposed to the nasal and oral microbial contents, differently from the enclosed cavity of the middle ear, this makes the adenoid more susceptible to be colonized by a higher load and more variety of microorganisms. It is generally accepted that the development of negative pressure within the middle ear cavity suctions microbial components of the nasopharyngeal microbiota but, at present, there is no enough data to rule out the establishment of a selected microbiome especial to the middle ear cavity.

Interestingly, adenovirus detection was more frequent in hypertrophic adenoid tissues from patients with OME than in normal adenoids from healthy controls. This is in agreement with a paper previously published by our group reporting high rates of adenovirus detection by PCR in hypertrophic adenoids [14]. It has not been clear whether adenovirus has any role in pathogenesis of adenoid hypertrophy, especially because this virus is also frequent in nasopharyngeal secretions from healthy individuals [28]. Since some HAdV species are more prone than others to have more prolonged shedding [29], prospective longitudinal studies of viruses in patients with hypertrophic tonsils should include determination of adenovirus species to evaluate whether they are associated with chronic tonsillar hypertrophy.

The observed association of HAdV with S. pneumoniae in adenoids could lead to speculate that the epithelial damage induced by HAdV could somehow favor the secondary local proliferation of S. pneumoniae [30]. Some viruses, for instance influenza, are known to favor pneumococcal colonization of the upper airways by multiple mechanisms, including exposure of receptors for pneumococcal adherence and by providing nutrients sources for bacterial growth [31]. However, the simultaneous presence of HAdV and S. pneumoniae in adenoid tissue could be independent observations, due to the high frequencies of both microorganisms in the adenoid.

S. pneumoniae and M. catarrhalis were detected more often in middle ear washes from OME patients than controls. Considering that S. pneumoniae and M. catarrhalis are the most frequent pathogens detected in acute otitis media [6], and are able to ascend through the Eustachian tube [32], causing ciliary damage to the airway epithelium and disrupting mucociliary flow, this may result in conditions for persistence in the middle ear compartment [3336]. In some cases, especially when OME is not clearly related to a mechanical obstruction of the Eustachian tube, the Toynbee effect of negative pressure within the middle ear may help ascendance of microbes through the tube, leading to colonization of the middle ear, which may be pivotal in OME pathogenesis.

M. catarrhalis has been widely studied because of its importance in middle ear diseases, and this interest has even led to vaccines for M. catarrhalis being proposed [37]. It’s mechanisms of adherence and triggering of the immune response have been well studied and even when not related to clinically relevant infection processes, appears with a high level of colonization during childhood [38]. Once regarded as nonpathogenic, M. catarrhalis could be related to several chronic affections of the upper airways [39].

Microorganisms in sessile biofilms are frequently resistant to the innate and adaptive immune responses and to antimicrobial agents. In OME, there has been evidence that the presence of middle ear fluid is associated to formation of biofilm in the middle ear, and that these biofilms are related to the local inflammation [9, 24]. In conventional, culture-based microbiology, detection of these microorganisms is not always possible, and the use of sensitive molecular methods, such as real-time PCR, enables detection of multiple microbes in complex niches like the middle ear. Although PCR cannot distinguish viable from dead microbes, the specificity of the primers coupled with careful sampling technique in order to minimize cross-contamination between sampling sites, ensure that the microorganisms were indeed present in the middle ear.

Viruses and bacteria interact in many different ways on different mucosal surfaces [40], including the upper respiratory tract mucosa and tonsils [41]. Persistence of viral infections includes a complete reprogramming of the local immune response, attenuation of production of type 1 interferon, and local alteration of the CD4+/CD8+ T cell balance [41, 42]. The airway mucosa affected by viral infection becomes more susceptible to bacterial adherence and mucosal inflammation [30, 43, 44]. Therefore, associations of viruses and bacteria could be acting in concert to modify the course of the OME. In the present study, there was an association of detection of HAdV and S. pneumoniae in adenoid tissues from patients with OME, suggesting that microbial correlations already described in acute middle ear disease [16, 45] could play a role in such chronic processes.

Clinical studies based on microbial detection in patients with adenoid hypertrophy and OME have rarely included a healthy control group. A notable example was a study of biofilms in middle ear samples, including adults and children [25]. Importantly, biofilms were not observed in OME patients, but not in control specimens of middle ear mucosa obtained from patients undergoing cochlear implantation, strongly suggesting that biofilm production is an important factor in development of OME. Through a minimally invasive method (MEW) and a very sensitive procedure (real time PCR), we were able to compare samples of healthy children with those of children with OME. In the light of that result, the findings of some potentially pathogenic bacteria in the middle ear of patients undergoing cochlear implant suggests that their presence in the middle ear is independent of biofilm formation. Unfortunately, in the present study no attempt was made to verify the presence of biofilm.

Concluding, in children with OME and adenoid hypertrophy we observed higher detection rates of potentially pathogenic bacteria, but not respiratory viruses, by real-time PCR in middle ear samples, as compared to control patients without adenoid hypertrophy. We did not observe correlation between the microbiota of adenoid and middle ear, neither in OME children nor in controls. This adds evidence that microbial community present in the middle ear may be associated with persistence of fluid and pathogenesis of OME.

Supporting information

S1 Table. Virus.

Primers and probes used for qPCR.


S2 Table. Bacteria.

Primers and probes used for qPCR.


Author Contributions

  1. Conceptualization: GPB EA ET WTA-L FCPV.
  2. Data curation: THS MCP.
  3. Formal analysis: GPB.
  4. Funding acquisition: WTA-L.
  5. Investigation: JLP-M TBG.
  6. Methodology: ET WTA-L LRC GPB EA.
  7. Project administration: WTA-L EA.
  8. Resources: EA.
  9. Supervision: EA WTA-L.
  10. Visualization: MAH ETM GPB.
  11. Writing – original draft: GPB.
  12. Writing – review & editing: ET MAH EA GPB.


  1. 1. Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, et al. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2004; 130: S95–118. pmid:15138413
  2. 2. Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology—Head and Neck Surgery. 2016; 154: S1–S41. pmid:26832942
  3. 3. Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012; 7: e36226. pmid:22558393
  4. 4. Alho OP, Oja H, Koivu M, Sorri M. Chronic otitis media with effusion in infancy. How frequent is it? How does it develop? Arch Otolaryngol Head Neck Surg. 1995; 121: 432–436. pmid:7702818
  5. 5. Koopman L, Hoes AW, Glasziou PP, Appelman CL, Burke P, McCormick DP, et al. Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: a meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg. 2008;134: 128–132. pmid:18283152
  6. 6. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004; 363: 465–473. pmid:14962529
  7. 7. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2006; 70: 639–645. pmid:16169093
  8. 8. Marseglia GL, Pagella F, Caimmi D, Caimmi S, Castellazzi AM, Poddighe D, et al. Increased risk of otitis media with effusion in allergic children presenting with adenoiditis. Otolaryngol Head Neck Surg. 2008; 138: 572–575. pmid:18439460
  9. 9. Saylam G, Tatar EC, Tatar I, Ozdek A, Korkmaz H. Association of adenoid surface biofilm formation and chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 2010; 136: 550–555. pmid:20566904
  10. 10. Wright ED, Pearl AJ, Manoukian JJ. Laterally hypertrophic adenoids as a contributing factor in otitis media. Int J Pediatr Otorhinolaryngol. 1998; 45: 207–214. pmid:9865437
  11. 11. Bhargava R, Chakravarti A. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children. J Laryngol Otol. 2014; 128: 1060–1066. pmid:25404102
  12. 12. Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P. The protective effect of adenoidectomy on pediatric tympanostomy tube re-insertions: a population-based birth cohort study. PLoS One. 2014; 9: e101175. pmid:24983459
  13. 13. Nistico L, Kreft R, Gieseke A, Coticchia JM, Burrows A, Khampang P, et al. Adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol. 2011; 49: 1411–1420. pmid:21307211
  14. 14. Proenca-Modena JL, Pereira Valera FC, Jacob MG, Buzatto GP, Saturno TH, Lopes L, et al. High rates of detection of respiratory viruses in tonsillar tissues from children with chronic adenotonsillar disease. PLoS One. 2012; 7: e42136. pmid:22870291
  15. 15. Huang H, Sun W, Liang Y, Peng Y, Long XD, Liu Z, et al. Comparative study of bacterial strains and antibiotic susceptibility tests between chronic tonsillitis patients with IgA nephropathy and without nephritis. Ren Fail. 2013; 35: 1334–1337. pmid:24003909
  16. 16. Pitkaranta A, Jero J, Arruda E, Virolainen A, Hayden FG. Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion. J Pediatr. 1998; 133: 390–394. pmid:9738723
  17. 17. Post JC, Preston RA, Aul JJ, Larkins-Pettigrew M, Rydquist-White J, Anderson KW, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. Jama. 1995; 273: 1598–1604. pmid:7745773
  18. 18. Wang DY, Bernheim N, Kaufman L, Clement P. Assessment of adenoid size in children by fibreoptic examination. Clin Otolaryngol Allied Sci. 1997; 22: 172–177. pmid:9160934
  19. 19. Parikh SR, Coronel M, Lee JJ, Brown SM. Validation of a new grading system for endoscopic examination of adenoid hypertrophy. Otolaryngol Head Neck Surg. 2006; 135:684–687. pmid:17071294
  20. 20. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis Manual de Normas e Procedimentos para Vacinação. Brasília: Ministério da Saúde, 2014. p. 176 p.
  21. 21. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993; 15: 532–534, 6–7. pmid:7692896
  22. 22. Jourdain S, Smeesters PR, Denis O, Dramaix M, Sputael V, Malaviolle X, et al. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins. Clin Microbiol Infect. 2011; 17: 907–914. pmid:20977542
  23. 23. Marchisio P, Claut L, Rognoni A, Esposito S, Passali D, Bellussi L, et al. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. Pediatr Infect Dis J. 2003; 22: 262–268. pmid:12634589
  24. 24. Saafan ME, Ibrahim WS, Tomoum MO. Role of adenoid biofilm in chronic otitis media with effusion in children. Eur Arch Otorhinolaryngol. 2013; 270: 2417–2425. pmid:23179928
  25. 25. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Jama. 2006; 296: 202–211. pmid:16835426
  26. 26. Proenca-Modena JL, Buzatto GP, Paula FE, Saturno TH, Delcaro LS, Prates MC, et al. Respiratory viruses are continuously detected in children with chronic tonsillitis throughout the year. Int J Pediatr Otorhinolaryngol. 2014; 78: 1655–1661. pmid:25128448
  27. 27. Liu CM, Cosetti MK, Aziz M, Buchhagen JL, Contente-Cuomo TL, Price LB, et al. The otologic microbiome: a study of the bacterial microbiota in a pediatric patient with chronic serous otitis media using 16SrRNA gene-based pyrosequencing. Arch Otolaryngol Head Neck Surg. 2011; 137: 664–668. pmid:21768410
  28. 28. Robb PJ. Otitis Media With Effusion. In: Graham JM, Scadding GK, Bull PD. (ed.). Pediatric ENT. Heidelberg: Springer; 2007. pp. 413–420.
  29. 29. Anderson BD, Barr KL, Heil GL, Friary JA, Gray GC. A comparison of viral fitness and virulence between emergent adenovirus 14p1 and prototype adenovirus 14p strains. J Clin Virol. 2012; 54: 265–268. pmid:22484030
  30. 30. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011; 24: 210–229. pmid:21233513
  31. 31. Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe. 2014; 16: 55–67. pmid:25011108
  32. 32. Emaneini M, Gharibpour F, Khoramrooz SS, Mirsalehian A, Jabalameli F, Darban-Sarokhalil D, et al. Genetic similarity between adenoid tissue and middle ear fluid isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from Iranian children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2013;77: 1841–1845. pmid:24080321
  33. 33. Sade J, Eliezer N. Secretory otitis media and the nature of the mucociliaryy system. Acta Otolaryngol. 1970; 70: 351–357. pmid:5505129
  34. 34. Carrie S, Hutton DA, Birchall JP, Green GG, Pearson JP. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol. 1992; 112: 504–511. pmid:1441992
  35. 35. Moyse E, Lyon M, Cordier G, Mornex JF, Collet L, Froehlich P. Viral RNA in middle ear mucosa and exudates in patients with chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 2000; 126: 1105–1110. pmid:10979124
  36. 36. Fliegauf M, Sonnen AFP, Kremer B, Henneke P. Mucociliary Clearance Defects in a Murine In Vitro Model of Pneumococcal Airway Infection. PLoS ONE. 2013; 8: e59925. pmid:23527286
  37. 37. Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002; 15: 125–144. pmid:11781271
  38. 38. Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis. 2009; 49: 124–131. pmid:19480579
  39. 39. Wood GM, Johnson BC, McCormack JG. Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners. Clin Infect Dis. 1996; 22: 632–636. pmid:8729201
  40. 40. Robinson CM, Pfeiffer JK. Viruses and the Microbiota. Annu Rev Virol. 2014; 1: 55–69. pmid:25821837
  41. 41. Jartti T, Palomares O, Waris M, Tastan O, Nieminen R, Puhakka T, et al. Distinct regulation of tonsillar immune response in virus infection. Allergy. 2014; 69: 658–667. pmid:24684577
  42. 42. Zuniga EI, Macal M, Lewis GM, Harker JA. Innate and Adaptive Immune Regulation During Chronic Viral Infections. Annu Rev Virol. 2015; 2: 573–597. pmid:26958929
  43. 43. Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG. Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol. 1993; 113: 642–648. pmid:8266793
  44. 44. Avadhanula V, Rodriguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC, et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol. 2006; 80: 1629–1636. pmid:16439519
  45. 45. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003; 113: 1645–1657. pmid:14520089